(MedPage Today) — Metformin failed to prevent metabolic syndrome in men on hormonal therapy for prostate cancer but did improve risk factors associated with the syndrome, an abbreviated randomized trial showed.
The proportion of patients with…
Source link : https://www.medpagetoday.com/hematologyoncology/prostatecancer/118196
Author :
Publish date : 2025-10-28 21:34:00
Copyright for syndicated content belongs to the linked Source.
